INTRODUCTION
Adverse reactions to iodinated contrast medium happen relatively frequently in daily work at imaging units, and their occurrence can range from light forms to life-threatening events. International studies indicate that these events occur in between 0.2 and 12.7% of contrast injections, depending on the type and characteristics of the radiopaque substance that is used (1) (2) . However, there are no national publications about the frequency of these reactions in Brazilian radiology services. Thus, this research aimed to find out about immediate adverse reactions presented by hospitalized patients submitted to computed tomography (CT) with intravenous iodinated contrast, at a teaching hospital in the South of Brazil. A further goal was to identify the frequency of these events and establish a parallel with results from international references. This knowledge can support care and management decisions, contributing to more qualified and specialized care delivery to clients submitted to tomographies.
LITERATURE REVIEW
Iodinated contrast is a radiopaque substance used in radiology exams like computed tomography, which is widely used for diagnostic purposes. Although it improves the visualization of anatomic structures during the exam, this substance can provoke unwanted adverse effects, mainly due to the contrast's high osmolality in relation to blood (3) . Ionic iodinated contrast is dissociated in ions when solved and its osmolality is higher than that of so-called non-ionic compounds, which do not dissociate into electricallyloaded particles. Therefore, the non-ionic medium is safer and has a better tolerability, but its high cost impedes its indiscriminate use (4) (5) . (2, 4) . Adverse reactions are called acute when they occur within 30 minutes after contrast administration and late when they occur after 30 minutes and up to seven days later (5) . Risk factors associated with the occurrence of adverse reactions to iodinated contrast include previous history of adverse reactions to radiopaque medium, history of asthma or allergies, heart arrhythmias, ischemic heart disease, general weakness, impaired communication,
anxiety, kidney failure, extreme age and concomitant use of some drugs, such as beta blockers, metformin and nephrotoxic agents (4) (5) (6) . The frequency of adverse events associated with iodinated contrast ranges between 2.2 and 12.7% when ionic medium is used and between 0.2 and 3.1% when non-ionic contrast is used (1) (2) 7) . Iodinated contrast extravasation is considered a local adverse effect of intravenous radiopaque substance administration. Most extravasations involve small volumes of less than 10 ml, evolving without complications; however, large volumes of 50 ml or more can damage neighboring tissues of the puncture site and, rarely, compartmental syndrome (6) . According to international literature (2, (8) (9) (10) , the frequency of radiopaque medium extravasation varies between 0.3% and 3.6%. Next, in the results section, findings related to extravasation of the radiopaque medium were described separately, as this is a local adverse effect for which different sample subject inclusion and exclusion criteria were adopted. significantly lower than when ionic contrast agent is used (p=0.000), supporting the assertion that the nonionic medium, with lower osmolality, drastically reduces the risk of adverse reactions (4) . Intensity of all events was light, with signs and symptoms receding spontaneously, and 54.6% of events started within the first ten minutes after contrast administration.
IMMEDIATE ADVERSE REACTIONS
In Table 1 , rates found in this study are compared with international references, showing no significant difference between these results and a Japanese research (1) . That study included feeling hot as an adverse reaction, with a frequency of 2.29% for ionic medium and 0.92% for non-ionic medium, while that symptoms was not considered here. Other authors (7) ignore not only feeling hot, but also the occurrence of vomiting. Therefore, when drawing a parallel with the results of that reference source, manifestations of vomiting were excluded. Result differences were significant for ionic iodinated contrast usage only;
however, it should be highlighted that those researchers do not distinguish between light and moderate reactions, grouping them in one single category of adverse reactions. This means that, although this study found a higher rate of adverse events when ionic contrast was used, these events were less severe, as they only referred to light reactions. 
As to the contrast volume used for each exam, it was observed that the radiopaque substance dose, expressed in ml/kg, is not a determinant factor for the occurrence of adverse reactions in general, neither for ionic nor for non-ionic iodinated contrast.
Some studies (1) (2) 8) with a significant decrease in frequencies for each year added to the patient's age. Hence, the younger the patient, the higher the probability of developing an immediate or late adverse reaction to iodinated contrast (12) . In fact, in this study, the frequency of reactions to the ionic medium decreased from the age of 30 onwards. However, no statistically significant difference occurred for adverse reactions in general in different age ranges (p=0.684).
Another important characteristic of clients in this study is that 76.6% of the sample subjects presented one or more risk factors for developing adverse reactions to the radiopaque substance, which were more frequent in people over 70 (25.6%), with a heart disease (16.0%), diabetes mellitus (11.1%) and various allergies (10.0%). Different studies (1, 12) indicate that the rate of adverse reactions increases about three to five times in the presence of factors like a history of previous reaction to iodinated contrast, various allergies and asthma. In this research, no significant difference was found in anaphylactoid adverse event rates with ionic iodinated contrast usage between the group with and the groups without allergic antecedents: 15.4% versus 10.2%, respectively, with p=0.911. No significant differences in extravasation rates were found between genders and age ranges.
RADIOPAQUE MEDIUM EXTRAVASATION
Venous network fragility was present in 100 of the 317 sample patients, five of whom presented extravasation. This corresponds to a 5.0% extravasation rate among patients in this condition.
However, the difference with the group without any risk factor was not statistically significant (p=0.101).
Literature (2, (8) (9) (10) about the occurrence of extravasation refers to research that used some criteria different from those used in this study, such as the exclusive use of plastic catheters, exclusive use of automatic injection and different criteria to select the research subjects. In comparing the results of this study with international references, attempts were made to adapt results from the HCPA to the criteria used by different researchers, as shown in Table 2 .
Only one international study (8) presented a significantly lower percentage than results obtained at the HCPA, although extravasated contrast volumes ranged from 3 to 144 ml, with a mean volume of 41 ml. Thus, although higher rates were found in this research, extravasated volumes were significantly lower. This was fundamental for the non-occurrence of drastic consequences in the exposed patients.
Moreover, other sources also mention higher extravasated volumes, ranging between 3 and 120 ml (9) , or do not specify the extravasated volumes (2) .
The reduced extravasated volumes in this study, corresponding to less than 10 ml, is attributed to the fact that a nursing professional stayed at the patient's side during the injection, identifying signs of extravasation at an early stage and interrupting the contrast flow in time to prevent more severe complications in patients exposed to this event. Table 2 -Comparison between extravasation rates found in international publications and in this study
Another study (10) 
FINAL CONSIDERATIONS
When associating these research results with available international references, some divergences appeared in terms of criteria used to study adverse reactions to iodinated contrast, such as the selection of sample subjects and the signs and symptoms considered by the researcher.
As to the study subjects, the fact that this sample exclusively consists of hospitalized patients suggests a higher rate of adverse events than in studies including outpatients. Some conditions that are very common among hospitalized patients have already been associated with a two-to fourfold increase in chances for the occurrence of adverse reactions to radiopaque medium, such as exposure to surgeries, invasive procedures or regular medication intake during the five days before the exam (12) . With respect to immediate adverse reactions, this research considered vomiting, while international studies (1, 7) exclude vomiting and include other symptoms, such as feeling hot and pain in the injection site. In other words, study results can only be compared when samples in equivalent health conditions are used and when the same research subject inclusion and exclusion criteria are adopted. However, due to the lack of information produced in conditions similar to this study context, references were used to provide parameters that could indicate the adequacy or inadequacy of local results.
In this study, immediate adverse reactions to iodinated contrast occurred at a frequency of 12.5%
among patients who received ionic medium and 1.0% among patients exposed to non-ionic contrast. Intensity levels of these events were light and they were solved spontaneously. These results are within the limits quoted in literature (1, 4, 7) , reflecting fully acceptable and What contrast extravasation is concerned, this occurred in 2.2% of radiopaque substance injections through peripheral venous access, also according to parameters found in literature (2, (8) (9) (10) . In a large majority of cases, extravasated volumes remained under 10 ml, without any complication deriving from contrast administration in the extravascular space.
As to the material used to establish venous access, the use of plastic catheters revealed to be significantly safer than the use of metallic needles. International literature already mentions this significant difference in extravasation risks when using both materials, and no other research was found that used metallic needles. Thus, the use of metallic needles should be reassessed, in view of the universal use of plastic access, and new studies should be carried out to test different materials, considering the cost-benefit relation of using alternative devices.
These recommendations, based on local research data, as well as the assessment of the respective interventions, evidence the presence of improvement cycles and quality management in the health work area. Quality management has become fundamentally important in health service management, to the extent that it emphasizes continuous improvement through scientific methods and data monitoring to support decision making, with a view to achieving maximum client satisfaction and minimizing risks that can jeopardize the intended quality and security (13) (14) .
Therefore, tomography services should get to know the occurrence rates of adverse events to radiopaque medium and the conditions in which they occur, so as to obtain evidence to assess the respective care processes.
The fact that the intensity of adverse events was light and that they evolved well does not exclude the need to maintain the work team always prepared for emergency care. Severe events cannot be previewed and can occur even when non-ionic contrast agent is used, including in low risk patients, and alternative image studies that provide the same or better diagnostic information should be considered before administering iodinated contrast.
